跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AVIDART 0,5 mg CAPSULAS BLANDAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AVIDART 0,5 mg CAPSULAS BLANDAS
Approved
STANDARD
AVIDART 0,5 mg CAPSULAS BLANDAS
Glaxosmithkline A.E.B.E.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 11, 2021
Approval ID
41b5825fcff7abcd
Company
Glaxosmithkline A.E.B.E.
Type
Standard
Approval Details
Approval Id
41b5825fcff7abcd
Drug Cima Aemps Name
AVIDART 0,5 mg CAPSULAS BLANDAS
Register Number
2578701
Holder Company Name
Glaxosmithkline A.E.B.E.
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2021-11-11
Dosage Form
CÁPSULA BLANDA
Dose
0,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Glaxosmithkline A.E.B.E.
Active Ingredients
DUTASTERIDA
0,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 11, 2021
Approval ID
41b5825fcff7abcd
Type
Standard
Back to CIMA-AEMPS Approvals
